Target intelligence / Profile preview

Cellular antioxidant defense pathways

Molecular classification
Other
01

Overview

The cellular antioxidant defense pathways comprise a complex network of enzymatic and non-enzymatic systems designed to maintain redox homeostasis and protect cells from oxidative damage caused by reactive oxygen species (ROS) [NIH, 1.3.2]. Key enzymatic components include superoxide dismutase (SOD), catalase, and glutathione peroxidase, while non-enzymatic defenses involve molecules like glutathione and vitamins C and E [Wikipedia, 1.3.4]. The master regulator of this system is the Nrf2-Keap1 pathway, which coordinates the transcriptional induction of numerous antioxidant and detoxification genes in response to oxidative stress [PubMed, 1.1.3]. Dysregulation of these pathways is implicated in a wide range of pathologies, including neurodegenerative diseases, cardiovascular disorders, and cancer, where oxidative stress drives tissue damage or promotes tumor progression [NIH, 1.3.1]. Therapeutic strategies often focus on activating these pathways to enhance cellular resilience or, conversely, inhibiting them in cancer cells to overcome chemoresistance [MDPI, 1.2.4]. Drugs such as dimethyl fumarate and various Nrf2 activators are used or being investigated to modulate these pathways for clinical benefit [PubMed, 1.1.3].

Other names
Antioxidant defense systemEndogenous antioxidant systemRedox homeostasis pathwaysAntioxidant response element (ARE) pathway
02

Mechanism of action

Activation of the Nrf2-ARE signaling pathway to induce expression of antioxidant and detoxification enzymes; direct scavenging of reactive oxygen species (ROS); restoration of glutathione levels.

03

Biological functions

Redox homeostasisOxidative stress responseCell survivalMetabolismDetoxification
04

Disease associations

CancerNeurodegenerative diseaseInflammationCardiovascular diseaseMetabolic diseaseAging
05

Safety considerations

Pro-survival effects in cancer cells (promoting chemoresistance)Off-target effects of electrophilic Nrf2 activatorsRisk of reductive stressInterference with physiological ROS signaling
06

Interacting drugs

Dimethyl fumarate

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)GSH/GSSG ratioNrf2 expressionSuperoxide dismutase activity

Beyond the preview

Go deeper on Cellular antioxidant defense pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular antioxidant defense pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call